Adverse Drug Reactions: Is the patient voice loud enough?
20 April 2011
Invitation to international conference supported by LJMU Professor.
Professor Janet Krska, School of Pharmacy and Biomolecular Sciences, has been involved in a major study funded by NIHR Health Technology Assessment (HTA) on patient reporting of suspected Adverse Drug Reactions (ADRs) to the UK Yellow Card Scheme. Professor Janet Krska has also recently been awarded Fellowship of the Royal Pharmaceutical Society.
The full results of this research will be published in June 2011, coinciding with a mid-summer meeting, jointly organised by the PRIMM (Prescribing and Research in Medicines Management) and Drug Safety Research Unit, to which academics and members of the public are invited to attend.
The research will highlight the important role which patients have in reporting suspected ADRs.
Title: ADRs: Is the patient voice loud enough?
Venue: Friends House, 173-177 Euston Road, London NW1 2BJ
Date: Friday 24 June 2011
This conference will focus on the role of patients in reporting suspected Adverse Drug Reactions to pharmacovigilance centres. It is the first conference of its kind, bringing together academic researchers and teachers, practitioners, pharmacovigilance experts and patients to learn more about and debate this topic. The conference will highlight what has been learned from studies of the UK Yellow Card Scheme and the work of Lareb in the Netherlands on how patients contribute to reporting of Adverse Drug Reactions and what we can learn from their experiences.
Confirmed Speakers include:
- Professor Tony Avery / Professor Janet Krska / Lorna Hazell – Evaluation of UK YCS
- Prof Kees van Grootheest – Netherlands Pharmacovigilance Centre
- Dr Shelley Gandhi – Medicines and Healthcare Regulatory Agency
- Dr Isabelle Moulton – European Medicines Agency
- Professor Simon Maxwell – Medical Education
Patient stories – their personal experiences of adverse reactions
Debate – what can academics and practitioners learn from patients?
Further information, abstract call and registration forms available at www.primm.eu.com